Yilmaz, Ahmet
Cui, Hanwei
Caligiuri, Michael A.
Yu, Jianhua
Funding for this research was provided by:
National Institutes of Health (AI129582)
National Institutes of Health (CA247550)
National Institutes of Health (NS106170)
National Institutes of Health (CA223400)
National Institutes of Health (CA210087)
National Institutes of Health (CA068458)
National Institutes of Health (CA163205)
Article History
Received: 16 September 2020
Accepted: 12 November 2020
First Online: 7 December 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: M.A. Caligiuri and J. Yu are the co-founders of CytoImmune Therapeutics, Inc. The other authors declare no competing interests.